Pressmeddelanden från Brain+

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

30 maj 2025 16:22

Brain+ A/S – Minutes of Annual General Meeting 28 maj 2025 08:46

Leading UK dementia care authority, Antony Hall, joins Brain+ as Strategic Advisor 26 maj 2025 08:48

Brain+ signs its second UK sales agreement on Ayla with Park Homes UK Group 15 maj 2025 23:27

Brain+ A/S convenes the Annual General Meeting for 2025 05 maj 2025 09:00

Brain+ selected for the NHS Dementia Innovators Programme in the UK 29 apr 2025 20:19

Brain+ publishes its Annual Report for 2024 16 apr 2025 11:15

Brain+ appoints CCO Devika Wood as new CEO 09 apr 2025 08:50

Brain+ announces directed issue of units to convertible loan providers and guarantors 03 apr 2025 08:41

Contract signed with Copenhagen Municipality on extended and expanded access to Ayla 02 apr 2025 08:47

Brain+ announces outcome of unit rights issue 26 mar 2025 08:35

Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units 25 mar 2025 12:56

Brain+ to close first UK Care Home partnership contract with Southcare Homes Group 19 mar 2025 14:44

Invitation to investor webinar to present new Board Observer, sales pipeline progress and ongoing Unit Rights Issue 19 mar 2025 08:42

Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators 17 mar 2025 08:59

The subscription period in Brain+’ rights issue of units begins today 11 mar 2025 10:54

UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer 10 mar 2025 08:31

The benefits of Ayla – your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals 06 mar 2025 08:50

Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million 12 feb 2025 12:02

Brain+ A/S – Minutes of Extraordinary General Meeting 30 jan 2025 13:47

Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding 28 jan 2025 18:33

Brain+ A/S – Notice of Extraordinary General Meeting 22 jan 2025 19:30

Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue 31 dec 2024 14:30

Brain+ announces change of Certified Advisor 10 dec 2024 08:45

Brain+ invites to investor webinar to update on UK commercial pipeline and status 05 dec 2024 08:51

Brain+ secures its first multi-year sales contract for Ayla – your CST Assistant with Syddjurs municipality 21 nov 2024 15:30

Invitation to Investor Webinar on Monday 25th of November at 15:30: Update on commercial status and new opportunities 01 nov 2024 11:57

Brain+ closes new Danish municipality sales contract on Ayla – your CST Assistant 21 okt 2024 11:54

Brain+ progresses UK commercial outreach and hosts the first of a series of webinars on the value of Cognitive Stimulation Therapy 11 okt 2024 09:04

Brain+ unveils new visual brand and website to elevate its Ayla Dementia Care solutions 07 okt 2024 11:50

Brain+ announces first day of trading in new shares from the TO 4 warrant exercise and the related directed issue 02 okt 2024 10:32

Brain+ launches Ayla – your CST Assistant into the UK dementia market 01 okt 2024 12:11

Brain+ announces the outcome of its series TO 4 warrant exercise and the decision to carry out a directed share issue to cover guarantor subscriptions 01 okt 2024 09:23

Ayla – your CST Assistant has been registered in the UK as a certified Medical Device Software for dementia therapy 25 sep 2024 10:43

Brain+ confirms imminent commercial launch of Ayla – your CST Assistant as a medical device in the UK 23 sep 2024 12:15

Brain+ informs of three product releases planned for 2025 and introduces a platform renaming as part of its UK commercialization 20 sep 2024 08:43

Brain+ A/S announces additional commitments of DKK 1.4 million in the ongoing TO 4 warrant exercise, which is now covered at 40.4%17 sep 2024 10:46

Brain+ A/S announces that its board and management provide commitments to cover 13.7% of the warrants of series TO 4 13 sep 2024 10:33

Brain+ is set to deliver on an ambitious UK commercial plan to reach recurring revenue of DKK 7-8 million by 2025 and DKK 25-27 million by 2027 13 sep 2024 09:08

Brain+ A/S announces the exercise price for its warrants of series TO 4 05 sep 2024 09:30

First patient enrolled in a clinical trial to evaluate Brain+’ next generation cognitive training technology for Mild Cognitive Impairment 03 sep 2024 08:30

Results from UK study of the CST-Assistant show clinical relevance, cost-benefit and product-market fit 30 aug 2024 12:35

Invitation to Investor Webinar on Tues 3 Sept 2024 at 16:00 CEST: H1 2024 report and new Chief Commercial Officer 29 aug 2024 19:08

H1 2024: Brain+ has executed successfully in accordance with its UK-focused commercial strategy towards proof-of-business and realized financial results as expected 27 aug 2024 12:30

The CER of the CST-Assistant validated for UK regulatory compliance, documenting the product’s clinical performance 23 aug 2024 08:50

Brain+ fully on track towards market entry and first sales in the United Kingdom in H2 2024 12 jul 2024 10:31

New UK Labour government will focus on healthtech and dementia treatment as part of UK healthcare reform 09 jul 2024 10:18

The CST Assistant v2.0 for Cognitive Stimulation Therapy (CST) now released in Denmark 05 jul 2024 13:34

Directed issue of units to guarantors and registration of shares from both the rights issue and the directed issue 28 jun 2024 10:00

Brain+ hires UK health tech rising star as Chief Commercial Officer 27 jun 2024 10:08

Brain+ A/S publishes the outcome of its rights issue of units 24 jun 2024 10:06

Brain+ obtains additional guarantee commitment in its ongoing rights issue 21 jun 2024 08:45

Last day for subscription in the ongoing rights issue 20 jun 2024 13:50

Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue 20 jun 2024 12:37

Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue 17 jun 2024 09:33

Brain+ establishes UK subsidiary 14 jun 2024 12:23

The CST-Assistant v2.0 is now ready for release in Denmark and on track for release in the UK end of Q3 2024 13 jun 2024 08:46

BioStock: Brain+ CEO - “CST is becoming the standard in dementia care”11 jun 2024 09:48

BioStock Investor Pitch: Brain+11 jun 2024 08:47

The subscription period in Brain+ unit rights issue begins today 04 jun 2024 08:30

Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue 03 jun 2024 11:51

First steps taken to integrate CST-Assistant training with the formal CST-education in DK – a key market gateway milestone, also paving way for the UK 31 maj 2024 13:59

Brain+ A/S: Publication of investment brochure 24 maj 2024 09:33

Brain+’ invites to online investor event with new Chairman 22 maj 2024 11:17

Minutes of Annual General Meeting in Brain+16 maj 2024 11:02

Brain+ informs of progress on its UK focused proof-of-business strategy plan 07 maj 2024 22:16

Brain+ A/S convenes the Annual General Meeting 07 maj 2024 13:03

Brain+ publishes its Annual Report for 2023 – A year of market access, product development and a refocused commercial strategy 07 maj 2024 08:52

Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan 02 maj 2024 08:30

Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark 30 apr 2024 13:48

Brain+’ CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia 30 apr 2024 11:51

Brain+ releases preliminary annual financial statements for 2023 29 apr 2024 09:45

Brain+ announces a change in its Financial Calendar for 2024 26 apr 2024 08:49

Successful educational CST course held with Malteser Germany based on the CST-Assistant 11 apr 2024 10:08

Brain+ announces registration of directed issue with the Danish Business Authority 10 apr 2024 11:03

Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority 26 mar 2024 16:31

Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments 26 mar 2024 09:20

Brain+ A/S specifies how to get TO 3 warrant compensation 20 mar 2024 10:54

Brain+ A/S announces last day of trading in its warrants of series TO 3 19 mar 2024 08:30

Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK 18 mar 2024 10:06

Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025 15 mar 2024 11:07

Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments 11 mar 2024 12:54

Brain+ announces that 58% of its warrants of series TO 3 are covered by early commitments 07 mar 2024 08:52

Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise 12 feb 2024 08:30

Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate 09 feb 2024 08:30

Brain+ partners with Quiddity Health, the #1 UK digital healthcare market specialist, to prepare UK market entry for CST-Therapist Companion 18 jan 2024 08:30

Brain+ signs two new Danish sales contracts on CST-Therapist Companion and updates on the product’s commercial potential 09 jan 2024 09:18

Brain+ announces a change in the Chief Financial Officer position 14 dec 2023 18:46

Brain+’s chairman to step down 14 dec 2023 13:25

Brain+ gets public grant of DKK 3.5 million to scale the implementation of CST-Therapist Companion in Denmark 11 dec 2023 08:30

Brain+ closes sales contract with Copenhagen municipality on CST-Therapist Companion to support dementia care and therapy 23 nov 2023 15:37

Brain+ nominated to CO-PI grant of up to DKK 3.5 million to scale implementation of CST-Therapist Companion into dementia care in Denmark 14 nov 2023 08:30

Brain+ and VIA University College start usability study on CST-Therapist Companion in Denmark 02 nov 2023 16:47

Brain+ announces a change to its Board of Directors 24 okt 2023 14:40

Brain+ announces registration with the Danish Business Authority and first day of trading of new shares 18 okt 2023 09:53

Brain+ announces the outcome of its series TO 2 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments 16 okt 2023 13:37

Brain+ presents its unique digital CST offerings at two key European dementia conferences in October 12 okt 2023 14:55

Brain+ announces additional commitments in the ongoing exercise of warrants of series TO 2 to reach now a coverage of almost 50%12 okt 2023 08:45

Commercial outlook and potential impact of grants and partnering activities 12 okt 2023 08:30

Brain+ A/S announces last day of trading in warrants of series TO 2 11 okt 2023 13:21

Minutes of the Extraordinary General Meeting